PMOS: What We Call It Shapes How We Treat It

A Name That Never Fit

Medicine has a naming problem. Diabetes insipidus — renamed in 2022 — had nothing to do with sugar, but the word “diabetes” sent generations of patients and clinicians looking in the wrong direction. Asperger’s syndrome, retired in 2013, described a spectrum as though it were a type. Reiter’s syndrome, now called reactive arthritis, carried the name of a physician later found to have conducted Nazi war crimes. In each case, the name shaped what was seen, what was treated, and what was missed. A historian of medicine put it plainly: disease names are always provisional, because they are human constructs.

PCOS was no different.

For decades, millions of women were handed a diagnosis built around an image on an ultrasound: polycystic ovary syndrome. The name implied the problem was in the ovaries. It implied there were cysts. And it implied that if you treated the ovaries — or managed the symptoms visible to a scan — you were treating the condition.

None of that was quite right.

In May 2026, after fourteen years of global collaboration involving more than fifty patient and professional organizations, and over 22,000 survey responses from women and clinicians worldwide, the condition was officially renamed. It is now called Polyendocrine Metabolic Ovarian Syndrome — PMOS.

The new name acknowledges what clinicians, researchers, and women themselves have long understood: this is not a disorder of the ovaries. It is a condition of the whole endocrine system, of metabolism, of hormonal interplay across the entire body. The ovaries are one part of a much larger story.

That shift — from organ-centric to systems-level — is significant. And for those of us who work at the intersection of women’s health and Ayurveda, it feels like modern medicine arriving at a conversation that ancient science never left.

Why the Name Mattered — and Why It Held Us Back

The old name did real harm. Research has shown that the misleading framing contributed to diagnostic delays for up to 70% of those with the condition. Women with none of the expected “cysts” were dismissed. Women with clear metabolic symptoms — insulin resistance, blood sugar dysregulation, inflammation — were undertreated because the framework kept pointing back to the ovaries. The name shaped what clinicians looked for, and what they didn’t.

The new name corrects this in three deliberate words:

Polyendocrine — recognizing that multiple hormonal systems are involved: insulin, androgens, neuroendocrine signaling. Not one gland. Not one hormone.

Metabolic — acknowledging that insulin resistance, weight changes, cardiovascular risk, and blood sugar dysregulation are not secondary to this condition. They are central to it.

Ovarian — honoring that ovulatory dysfunction and reproductive impact remain real and defining features, without reducing the whole condition to them.

This is what it looks like when a medical framework expands to meet the complexity of what it’s describing. And it raises a deeper question: if the name was limiting how we saw the condition, what else might our frameworks be limiting?

Same Diagnosis. Different Bodies. Different Stories.

Two women receive the same diagnosis. One struggles with weight gain, intense sugar cravings, and irregular cycles. The other is lean and athletic and hasn’t missed a workout in years — and yet she hasn’t ovulated consistently in months. One has acne and excess body hair. Another has none of those symptoms and discovers the condition only when trying to conceive.

Same diagnosis. Completely different bodies. Completely different stories.

Modern medicine has tried to account for this by identifying distinct presentations — sometimes called subtypes, though these are not yet formally classified. Most clinicians recognize four dominant patterns:

Insulin-resistant: characterized by weight gain, sugar cravings, elevated insulin, and metabolic dysfunction.
Inflammatory: often linked to chronic low-grade inflammation, digestive dysregulation, or environmental triggers.
Adrenal: driven primarily by elevated stress hormones and adrenal androgen production.
Lean: present in women with normal body weight who nonetheless experience ovulatory disruption and hormonal imbalance.

These are useful clinical observations. But Ayurveda offers something these categories don’t: a framework for why this variation exists in the first place — one that was built around individual difference from the very beginning.

What Ayurveda Sees When It Looks at Women’s Health

Ayurveda does not begin with a condition. It begins with a person.

Central to Ayurvedic medicine is the concept of prakriti — an individual’s constitutional nature, determined by the balance of three fundamental energies, or doshas: Vata, Pitta, and Kapha. These are not personality types or wellness archetypes. They are functional principles that govern how energy moves, how metabolism works, how the nervous system responds, how tissues are nourished and cleared. (Cha. Sa. Sharira Sthana 3/3, 4/4)

Each person’s prakriti is unique, and each person’s state of imbalance — their vikriti — is also unique. Ayurveda has never operated under the assumption that two people with the same cluster of symptoms have the same underlying pattern. It has always asked: in this body, in this woman, at this point in her life, where has the balance shifted?

When we look at PMOS through this lens, the variation that baffled modern medicine for decades becomes legible.

A woman with a predominantly Vata imbalance may present with irregular or absent cycles, anxiety, poor sleep, a tendency toward low body weight, and a nervous system that is chronically dysregulated. The energy of movement is erratic — and that erraticism shows up in hormonal timing and ovulation.

A woman with elevated Pitta may present with inflammation as the primary driver — acne, heat, intensity, liver stress, elevated androgens, a body that runs hot and reactive. Her cycles may be heavy or painful when they do occur.

A woman with Kapha predominance may carry more weight, experience sluggish metabolism, thyroid involvement, high insulin, and the kind of heaviness and congestion that underlies insulin-resistant presentations. Her system moves slowly, accumulates, and holds.

These are not rigid boxes. Most women express a combination. But the point is this: Ayurveda built its entire framework around the truth that modern medicine is only now formally acknowledging — that the same syndrome expresses differently in different constitutions, and that treatment must meet the individual, not just the diagnosis.

Agni: The Fire at the Center of Everything

One of Ayurveda’s most foundational concepts is agni — digestive fire, but more broadly, the metabolic intelligence of the body. Agni governs how we transform what we take in: food, yes, but also experiences, emotions, sensory input. When agni is strong and balanced, nourishment reaches the tissues. When agni is impaired — either too weak, too sharp, or irregular — the result is ama: unprocessed residue that accumulates in the body and becomes the substrate for disease.

Consider this alongside what the PMOS rename now makes explicit: that metabolic function is not peripheral to this condition, it is central. Insulin resistance, the most common thread across all presentations, is precisely a failure of metabolic intelligence — the body’s inability to properly process and transform what it receives.

Ayurveda would not be surprised by this. The Charaka Samhita describes digestion as a cascade: food essence (ahara rasa) nourishes the first tissue layer, rasa dhatu, which in turn nourishes the blood, then muscle, fat, bone, marrow, and finally the reproductive tissues — each transformation dependent on the metabolic fire of the tissue preceding it. (Cha. Sa. Sutra Sthana 28/4; Chikitsa Sthana 15/16) The process is compared to milk becoming curd, curd becoming butter, butter becoming ghee — each stage enabling the next, each stage foreclosing on it if something earlier is impaired.

Artava — the menstrual and reproductive tissue — arises as an upadhatu, a secondary constituent, of rasa dhatu during this process. (Cha. Sa. Chikitsa Sthana 15/17) The Ashtanga Hridayam goes further: the agni operating specifically at the level of rasa dhatu directly influences artava’s formation. (A.Hr. Sharira Sthana 1/7, Arunadatta) What this means in practice is that the quality and regularity of menstruation is not a standalone phenomenon. It is a readout of the entire metabolic chain upstream of it — beginning with digestion.

If agni is impaired and ama accumulates anywhere in that chain, the reproductive system is among the first to reflect it. Irregular cycles, anovulation, and hormonal disruption are not isolated malfunctions. They are downstream signals of upstream imbalance.

This does not mean the ovaries are irrelevant. It means they are speaking on behalf of the whole.

The Preventative Vision: Knowing Yourself Before the Syndrome Arrives

PMOS does not arrive suddenly. It develops over time, through the slow accumulation of small imbalances — in sleep, in stress, in food, in the rhythms of rest and activity. Many women, looking back, can identify years of signals that were present before any clinical threshold was crossed: the cycles that gradually became irregular, the energy that slowly dimmed, the sugar cravings that appeared, the skin that changed.

An Ayurvedic approach to women’s health asks us to cultivate the kind of self-knowledge that can read those signals early — not with anxiety, but with curiosity and responsiveness. This is what a truly preventative framework looks like: not waiting for a syndrome to be named before paying attention, but developing an ongoing, intimate relationship with the rhythms of your own body.

Practically, this involves several things that Ayurveda has long emphasized and that modern research is beginning to validate:

Dinacharya — daily rhythm. Consistent sleep and wake times, meals at regular intervals, periods of stillness in a life that is otherwise in motion. The body’s hormonal systems are deeply circadian. Disrupting daily rhythm disrupts hormonal rhythm.

Seasonal and cyclical awareness. Ayurveda has always understood women’s bodies as cyclical — not just monthly, but seasonally, across life phases. Supporting the body through its natural transitions, rather than overriding them, is part of what keeps the whole system in communication with itself.

Digestive health as foundational. Before addressing hormones directly, Ayurveda asks: what is the state of digestion? Is food being metabolized well? Is the gut clear? Is ama accumulating? These questions are not separate from reproductive health — they are upstream of it.

Nervous system regulation. Chronic stress is a known driver of elevated cortisol and adrenal androgens — directly relevant to adrenal-pattern PMOS presentations. Ayurveda has an entire system of practices — abhyanga (self-massage with warm oil), pranayama, adapted yoga, and rasayana (rejuvenative tonics) — aimed specifically at restoring the nervous system’s capacity to regulate itself.

A Co-Creative Approach to Your Own Health

What the PMOS rename signals, at its deepest level, is that the medical framework is moving toward greater complexity, greater individualization, and greater acknowledgment that this condition cannot be addressed by targeting a single organ or a single biomarker.

That is exactly where Ayurveda lives.

The invitation, for any woman navigating this condition or trying to stay ahead of it, is not to abandon modern medicine — its tools for diagnosis, its research, its precision — but to bring the two frameworks into conversation. To let the PMOS diagnosis tell you what is happening in clinical terms, and to let Ayurveda help you understand why it is happening in your particular body, and what your body’s own intelligence might need to restore its balance.

That is a co-creative approach to health. Not passive. Not purely managed. Not reduced to a label or a prescription. But genuinely participatory — you as someone who knows your own constitution, your own rhythms, your own patterns of balance and disruption, working alongside practitioners who can offer both the modern clinical picture and the ancient systems wisdom.

The name changed. But the real shift is in what we’re willing to see.

References

Modern sources

Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. May 2026. doi:10.1016/S0140-6736(26)00717-8
Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. Press release, May 2026. endocrine.org
Ramel L. How disease names change — and why PCOS is the latest example. Newsweek. May 14, 2026. newsweek.com
Refardt J, Winzeler B, Christ-Crain M. Changing the name of diabetes insipidus: a position statement of the Working Group for Renaming Diabetes Insipidus. Journal of Clinical Endocrinology & Metabolism. 2022. PMC9578068

Classical Ayurvedic sources

Charaka Samhita, Sutra Sthana 28/4 — on the formation of rasa dhatu from food essence (ahara rasa) and the sequential nourishment of the seven tissue layers. Vividhashitapitiya Adhyaya.
Charaka Samhita, Chikitsa Sthana 15/16–17 — on the cascade of dhatu transformation and artava (menstrual blood and ovum) as an upadhatu arising from rasa dhatu metabolism. Grahani Dosha Chikitsa.
Ashtanga Hridayam, Sharira Sthana 1/7 (commentary of Arunadatta) — on the direct influence of agni at the rasa dhatu level on the formation of artava.
Ashtanga Hridayam, Sutra Sthana 9/4 — on the seven primary functions of the dhatus, with reproductive capacity (garbhottpadana) as the function of the final tissue in the sequence.
Charaka Samhita, Sharira Sthana 3/3 and 4/4 — on prakriti and the constitutional factors that determine an individual’s characteristic pattern from conception onward.

This article is for educational purposes and reflects the author’s integrative perspective. It is not intended as medical advice. If you are experiencing symptoms consistent with PMOS, please work with a qualified healthcare provider.